Marca Nominativa depositada no INPI em 19/06/2023 por Biocare Medical, LLC, processo nº 501742629, nas classes 01, 05. Registro em vigor até 19/06/2033.
| Número do processo | 501742629 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 19/06/2023 |
| Data da concessão | 21/01/2025 |
| Vigência até | 19/06/2033 |
| Titular | Biocare Medical, LLC |
| CNPJ/CPF do titular | — |
| UF · País | — · US |
Chemicals, namely, buffers for hybridization; diagnostic preparations for scientific or research use; diagnostic kits composed of DNA probes, reagents and antibodies for scientific research; biochemicals for use in scientific and medical research, namely, engineered and natural cytokinses, growth factors, proteins, hormones, enzymes, receptors, toxins, antigens and antibodies for the regulation of human, animal, plant, viral, and microbial genes for use in scientific and medical research; assays for research purposes; biochemical preparations for scientific purposes; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biochemical reagents used for non-medical purposes; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical preparations, namely, silica based density centrifugation media, to be used in biochemical and clinical research; chemical test kits for extracting DNA and RNA for laboratory or research use; enzymes for use in protein hydrolysis; protein arrays and nucleotide arrays for scientific and medical research; protein in raw material form for scientific and medical research; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use.;
Diagnostic kits composed of DNA probes, reagents and antibodies for clinical medical laboratory use; biochemical nucleic acid reagent probes for medical diagnostic use; reagents for detecting cancer for medical diagnostic use; cancer diagnostic kit comprised of medical diagnostic reagents and assays.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501742629 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.